echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The first love carry air Carnival held in Guangzhou

    The first love carry air Carnival held in Guangzhou

    • Last Update: 2019-12-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    According to the report of the World Health Organization, more than 90% of women in the world suffer from different degrees of gynecological diseases, while the number of women in China who die from gynecological diseases is as high as 200000 every year! Breast cancer, ovarian cancer and cervical cancer are of great concern among all the high-risk female cancers known as "beauty killer" The diagnosis of every malignant tumor means that it casts a shadow of death on the patients In the shadow of death, they seek medical advice and struggle with one difficult decision after another This is the unfortunate experience of every patient, but it is not the whole challenge As long as they are treated actively, cancer patients can see the light of life Recently, the first love air Carnival opened in Guangzhou windmill square, There are lectures and consultation from medical experts, popularization of the latest gene detection knowledge, prevention of recurrence and metastasis, prevention and treatment of lymphedema, popularization of common sense of breast maintenance, use of breast righteousness, and wonderful activities such as handicraft production, painting and calligraphy teaching, hair righteousness scissors, anti-cancer stars and stage show of anti-cancer Art Troupe Thousands of breast and ovarian cancer patients participated with their families It is understood that most of the patients participating in this carnival are breast cancer In the report of CSCO in 2019, some experts mentioned that the 5-year survival rate of breast cancer patients in China has reached 83.2% at present, which has increased by 7.3% in the past 10 years, which is very considerable To this end, Shi Anli, chairman of Beijing Aipu cancer care foundation, said that breast cancer is generally a malignant tumor with a better prognosis As long as we adhere to standardized treatment, most breast cancer patients will eventually recover After long-term survival, patients not only need to adhere to regular follow-up, but also need to form and adhere to a healthy lifestyle in daily life, so as to better improve the treatment effect and improve the quality of life In the "breast cancer treatment" expert lecture, Professor Xia Wen of cancer prevention and treatment center of Sun Yat sen University introduced that in all breast cancer patients, hormone receptor positive breast cancer accounts for the vast majority For this type of patients, endocrine therapy is an excellent strategy Endocrine therapy can effectively inhibit estrogen by reducing the level of estrogen in patients or not letting estrogen play a role Growth and reproduction of breast cancer cells For the early patients, it is possible to achieve a complete cure For the late metastatic breast cancer, the treatment goal is to extend the survival time without affecting the quality of life of the patients It is worth noting that the latest CSCO breast cancer diagnosis and treatment guidelines put frevist group at the first level of endocrine treatment recommendation It is the endocrine list with the best clinical evidence at present, which brings great hope for the survival of patients Ovarian cancer is the most lethal tumor in the female reproductive system According to the "2003-2015 changes in the survival rate of cancer patients in China" published in the lancet in 2018, the 5-year survival rate of malignant tumors in China has increased from 30.9% 10 years ago to 40.5%, while the 5-year survival rate of ovarian cancer has only increased by 0.4%, almost no significant improvement Every year, there are about 50000 new ovarian cancer patients in China Due to the lack of effective screening methods, 70-80% of the patients have been diagnosed in the late stage Therefore, in this carnival, the exhibition stand in the field of gene detection has become a hot topic Professor He Shanyang, the First Affiliated Hospital of Sun Yat sen University, said that about 1 / 4 of ovarian cancer patients in China had BRCA gene mutations For eligible patients with ovarian cancer, the results of BRCA gene detection can help to determine whether there is familial genetic mutation, guide the formulation of treatment plan, and judge the prognosis of the disease Professor he pointed out that ovarian cancer is a disease that is easy to recur With the increase of the number of disease recurrences, the time of disease-free progress will be shorter The most important reason for the short survival period of ovarian cancer is that it is difficult to operate after recurrences and it is difficult to choose drugs At present, the treatment of ovarian cancer is based on radical tumor reduction surgery and chemotherapy based on platinum drugs After treatment, close follow-up is needed, and if recurrence is found, timely treatment is needed With the increase of recurrence, patients may gradually develop from being sensitive to platinum drugs to be resistant to platinum drugs, and lack of effective treatment after platinum resistance Fortunately, the maintenance treatment of ovarian cancer makes it possible to reduce or delay the recurrence of ovarian cancer Through the whole process management of the new model, is expected to make ovarian cancer patients get longer-term survival benefits.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.